US biotech company Amyris has reported the first sale of its renewable product squalane by collaboring with a green ingredient supplier to the cosmetics industry.
“Successful industrial production of our first renewable product to our first customer is a point of celebration for Amyris, validating the success of our platform and the value of our products,” said John Melo, CEO of Amyris.
“We continue to scale our production while providing the reliable quality and delivery that our customers expect.”
France-based ingredients supplier Soliance placed the order following collaboration with Amyris and believes the product will enrich the market.
'Novel value proposition'
“We believe we have a novel value proposition in the market,” said Frederique LaFosse, general manager of Soliance.
“The combination of a reliable, high purity, renewable squalane can provide confidence to formulators the world over to use more of this best-in-class emollient,” he added.
Squalane is a moisturizing ingredient used in a wide range of cosmetics, currently sourced from refined olive oil or shark liver oil.
Amyris claims its squalane is renewable, of high purity and excellent stability, and has been successfully tested by Soliance and other potential customers.
Squalene set for market expansion
Both parties involved in the collaboration believe squalane may be used for expanded consumer applications which today rely on non-sustainable materials.
Amyris renewable squalane was produced by manufacturing Amyris’s Biofene, its renewable farnesene, and then converting it to squalane.
Last month Amyris announced that it has completed tests to engineer yeast to produce its renewable fragrance farnesene Biofene on an industrial scale, a process that lowers operational risks as well as gaining a valuable insight into how its yeast will perform at a commercial level.